Oxford BioMedica accelerates viral vector development and manufacture
(Alliance News) - Oxford Biomedica PLC on Monday announced the launch of fast-track offering for adeno-associated viral vectors and lentiviral vector platforms. Read More
| Price | 625.00p on 14-04-2026 at 18:40:08 |
|---|---|
| Change | 53.00p 9.27% |
| Buy | 623.00p |
| Sell | 618.00p |
| Last Trade: | Unknown 500.00 at 625.00p |
| Day's Volume: | 322,452 |
| Last Close: | 625.00p |
| Open: | 579.00p |
| ISIN: | GB00BDFBVT43 |
| Day's Range | 577.00p - 625.00p |
| 52wk Range: | 270.50p - 950.00p |
| Market Capitalisation: | £755.62m |
| VWAP: | 612.82428p |
| Shares in Issue: | 120.90m |
Oxford Biomedica (OXB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 500 | 625.00p | OTC Trade |
17:07:43 - 14-Apr-26 |
| Buy* | 1,796 | 625.00p | Automatic Execution |
16:35:20 - 14-Apr-26 |
| Buy* | 112,372 | 625.00p | Suspected BUY Trade |
16:35:11 - 14-Apr-26 |
| Sell* | 46 | 620.00p | Automatic Execution |
16:29:55 - 14-Apr-26 |
| Sell* | 16 | 620.00p | Automatic Execution |
16:29:55 - 14-Apr-26 |
| Sell* | 4,575 | 620.605p | Ordinary |
16:29:37 - 14-Apr-26 |
| Buy* | 55 | 621.00p | Automatic Execution |
16:29:26 - 14-Apr-26 |
| Buy* | 92 | 621.00p | Automatic Execution |
16:29:26 - 14-Apr-26 |
| Buy* | 43 | 621.00p | Automatic Execution |
16:29:26 - 14-Apr-26 |
| Sell* | 175 | 620.28p | Ordinary |
16:29:25 - 14-Apr-26 |
Oxford Biomedica (OXB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Apr 2026 7:00 am | RNS-R | Launch of viral vector fast-track offering |
| 8th Apr 2026 5:18 pm | RNS | Grant of Awards |
| 1st Apr 2026 7:00 am | RNS | Total Voting Rights |
| 30th Mar 2026 3:30 pm | RNS | 2026 Annual General Meeting notification |
| 26th Mar 2026 7:00 am | RNS | Preliminary results for the year ended 31 Dec 2025 |
| 18th Mar 2026 7:00 am | RNS-R | Licensing agreement with VVMF |
| 9th Mar 2026 7:53 am | RNS | Admission to Trading |
| 4th Mar 2026 11:45 am | RNS | Admission to Trading Application |
| 3rd Mar 2026 7:00 am | RNS | Capital Markets Day and investor conferences |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |